BFM
CNCE

Boothbay Fund Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Boothbay Fund Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-18,414
Closed -$108K – 2349
2022
Q4 		$108K Buy
+18,414
New +$108K ﹤0.01% 1524
2021
Q1 		– Sell
-10,000
Closed -$126K – 1666
2020
Q4 		$126K Buy
+10,000
New +$126K ﹤0.01% 996